Thomas Ebeling is a prominent German business executive known for his leadership in media and pharmaceuticals. Born on January 1, 1959, he earned a degree in psychology from a university in Hamburg in 1987. Ebeling began his career at Reemtsma Cigarettenfabriken GmbH as a product manager from 1987 to 1991, handling brands like 'West'. In 1991, he joined Pepsi-Cola Germany as a marketing manager, advancing to National Sales and Franchise Director by 1994. By 1997, he transitioned to Novartis Nutrition as General Manager for Germany and Austria, eventually rising to CEO of Novartis from 2005 to 2010. From 2000 to 2010, he simultaneously served as CEO of ProSiebenSat.1 Media, driving significant growth in broadcasting and digital media sectors and transforming the company into a major player in German entertainment. After leaving ProSiebenSat.1, he continued as Novartis CEO until 2010. Post-Novartis, Ebeling held supervisory board positions, including at Bayer AG from 2012 to 2019, QIAGEN NV from 2017 to 2024, and others in media and healthcare industries. His career reflects expertise in marketing, sales, and executive management across consumer goods, nutrition, and media.